ストックスクリーナーアプリを入手
0.851
1.77%
0.0148
アフターアワーズ：
.87
0.019
+2.23%
Biofrontera Inc (BFRI) 最新ニュース
Biofrontera's Stock Sale: Weighing Dilution Risks Against Biotech Sector Opportunities - AInvest
What makes Biofrontera Inc. stock price move sharplyFree Stock Selection - Newser
How Biofrontera Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser
How Biofrontera Inc. Equity Warrant stock performs during market volatilityFree Discussion Group - Newser
What makes Biofrontera Inc. Equity Warrant stock price move sharplyBig Return Stock Tips - Newser
Why Biofrontera Inc. Equity Warrant stock attracts strong analyst attentionVerified Return Tips - Newser
Why Biofrontera Inc. stock attracts strong analyst attentionHigh Return Setup Scanner - Newser
BFRI’s Stock Dilemma: Biofrontera Inc’s Market Performance and Outlook - investchronicle.com
Biofrontera restructures relationship with Biofrontera AG, backed by $11M investment - MSN
Q3 Earnings Forecast for Biofrontera Issued By Roth Capital - Defense World
Biofrontera Inc. restructures relationship with Biofrontera AG - TipRanks
Biofrontera stock rises after restructuring agreement with Biofrontera AG - Investing.com
Biofrontera Finalizes Acquisition of U.S. Ameluz Rights - TipRanks
Biofrontera Inc. announced that it expects to receive $11 million in funding from Aigh Capital Management, LLC, Rosalind Advisors, Inc. - MarketScreener
Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment - GlobeNewswire
Biofrontera Restructures U.S. Rights with $11M Investment - TipRanks
PTA-Adhoc: Biofrontera AG: EXTENSION OF BIOFRONTERA INC. PAYMENT DEFERRALUPDATE - TradingView
Biofrontera AG Extends Payment Deferral Amid Strategic Negotiations - TipRanks
Biofrontera Holds Annual Stockholders Meeting, Key Decisions Made - TipRanks
Biofrontera AG Extends Payment Deferral Amid Ongoing Negotiations - TipRanks
Short Interest in Biofrontera Inc. (NASDAQ:BFRI) Increases By 74.8% - Defense World
Biofrontera Inc. (BFRI) Engages in Strategic Talks with Biofront - GuruFocus
National Crime Prevention Council Urges McDonald's to End Snapchat Partnership Over Child Safety Concerns - The Manila Times
Biofrontera Inc. Confirms Talks on Merger, Licensing Changes with Biofrontera AG - MarketScreener
Biofrontera Inc. Negotiates Cooperation Changes with Biofrontera AG - TipRanks
Biofrontera in talks with AG parent for possible merger or deal terms - Investing.com India
Biofrontera Inc. Confirms Negotiations for Potential Combination with Biofrontera AG - Nasdaq
Biofrontera in talks with AG parent for possible merger or deal terms By Investing.com - Investing.com South Africa
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG - GlobeNewswire
Biofrontera Inc Explores Merger with Parent Company, Major US License Agreement Changes on Table - Stock Titan
Biofrontera AG Explores Strategic Changes with Biofrontera Inc. - TipRanks
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update - mx.advfn.com
Actinic Keratosis Treatment Market SWOT Analysis by Leading Expert: Almirall, Biofrontera, Nestle - newstrail.com
Biofrontera secures patent for Ameluz formulation until 2043 By Investing.com - Investing.com South Africa
biofrontera inc. revises proxy statement disclosure By Investing.com - Investing.com South Africa
biofrontera inc. revises proxy statement disclosure - Investing.com
Biofrontera Updates Proxy Statement for 2025 Meeting - TipRanks
Biofrontera Glycol-Free Skin Gel Added to FDA 'Orange Book;' Shares Rise - marketscreener.com
Biofrontera Inc. (BFRI) Propylene Glycol-Free Patent Gains FDA R - GuruFocus
Biofrontera Inc. (BFRI) Propylene Glycol-Free Patent Gains FDA Recognition | BFRI Stock News - GuruFocus
Biofrontera secures patent for Ameluz formulation until 2043 - Investing.com
Biofrontera announces inclusion of patent in FDA Orange Book - TipRanks
Biofrontera Inc. Announces Patent for Propylene Glycol-Free - GlobeNewswire
1.09%
3.10%
大文字化:
|
ボリューム (24 時間):